IRIS - Res&Arch Institutional Research Information System - Research & Archive

FAGOTTI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.282
EU - Europa 2.966
AS - Asia 2.209
SA - Sud America 664
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 9.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.216
SG - Singapore 1.141
IE - Irlanda 610
RU - Federazione Russa 536
BR - Brasile 518
SE - Svezia 386
UA - Ucraina 349
IT - Italia 315
CN - Cina 261
VN - Vietnam 239
HK - Hong Kong 222
DE - Germania 217
FI - Finlandia 194
FR - Francia 177
AR - Argentina 56
IN - India 56
GB - Regno Unito 52
TR - Turchia 48
BD - Bangladesh 36
CA - Canada 28
CH - Svizzera 27
IQ - Iraq 27
PK - Pakistan 27
ID - Indonesia 26
CO - Colombia 25
EC - Ecuador 25
UZ - Uzbekistan 22
AT - Austria 18
PL - Polonia 18
ZA - Sudafrica 18
MX - Messico 15
NL - Olanda 15
MA - Marocco 13
SA - Arabia Saudita 13
TN - Tunisia 13
KR - Corea 12
CZ - Repubblica Ceca 11
ES - Italia 11
LB - Libano 11
JP - Giappone 10
KE - Kenya 10
CL - Cile 9
VE - Venezuela 9
EG - Egitto 8
ET - Etiopia 8
PH - Filippine 8
EU - Europa 6
GR - Grecia 6
JO - Giordania 6
LT - Lituania 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BO - Bolivia 5
NI - Nicaragua 5
PY - Paraguay 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
IL - Israele 4
JM - Giamaica 4
MY - Malesia 4
UY - Uruguay 4
AU - Australia 3
DZ - Algeria 3
KG - Kirghizistan 3
NP - Nepal 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BG - Bulgaria 2
GE - Georgia 2
HR - Croazia 2
KZ - Kazakistan 2
LY - Libia 2
NG - Nigeria 2
PS - Palestinian Territory 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
GA - Gabon 1
GP - Guadalupe 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
Totale 9.208
Salva come PNG Salva come JPEG
Città #
Singapore 705
Dublin 610
Chandler 463
San Mateo 328
San Jose 243
Boardman 225
Hong Kong 222
Moscow 189
Santa Clara 181
Altamura 174
Medford 167
Princeton 164
Lauterbourg 144
Lawrence 121
Ashburn 120
Wilmington 116
Andover 113
Dong Ket 113
Ho Chi Minh City 57
Saint Petersburg 50
Beijing 43
São Paulo 38
New York 37
Falls Church 34
The Dalles 30
Los Angeles 29
Norwalk 27
Ann Arbor 26
Munich 21
Hanoi 20
Cattolica 19
Izmir 19
Helsinki 18
Rome 17
San Paolo di Civitate 17
Baghdad 16
Nuremberg 16
Columbus 15
Des Moines 15
Perugia 15
Rio de Janeiro 14
Chicago 12
Da Nang 11
Hanover 11
Medellín 11
Seoul 11
Brasília 10
Dhaka 10
Milan 10
Tokyo 10
Ankara 9
Den Haag 9
Guayaquil 9
Johannesburg 9
Tashkent 9
Boston 8
Phoenix 8
Porto Alegre 8
Quito 8
Turku 8
Addis Ababa 7
Belo Horizonte 7
Caivano 7
Curitiba 7
Jacksonville 7
Manchester 7
Montreal 7
Nairobi 7
Warsaw 7
Amman 6
Campinas 6
Dallas 6
Fortaleza 6
Manaus 6
Orem 6
Santiago 6
Santo André 6
Shanghai 6
Buenos Aires 5
Cairo 5
Campo Grande 5
Caxias do Sul 5
Chennai 5
Guarulhos 5
Haiphong 5
Houston 5
Islamabad 5
Istanbul 5
Jeddah 5
Karachi 5
Managua 5
Mumbai 5
New Delhi 5
Recife 5
Ribeirão Preto 5
Riyadh 5
Salto 5
Sorocaba 5
Tappahannock 5
Vienna 5
Totale 5.399
Salva come PNG Salva come JPEG
Nome #
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series. 111
Laparoendoscopic single-site surgery for fertility-sparing staging of border line ovarian tumors: initial experience. 92
Isterectomia laparoscopica semplice e radicale: terminologia, classificazione e tecnica chirurgica. In: Isterectomia laparoscopica. 89
Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. 86
Chirurgia nella terapia primaria del carcinoma ovarico 85
Advanced ovarian cancer: diagnosis and prediction of optimal cytoreduction 85
A multi-centric trial to validate the reliability of a laparoscopic score to assess intraperitoneal diffusion of the advanced ovarian cancer 85
Isterectomia laparoscopica: chirurgica single-port e mini-laparoscopia 84
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 84
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 83
Reply to "Let’s Think Twice Before Abandoning Fibrillar Oxidized Regenerated Cellulose" 81
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up. 80
Laparoscopy and ovarian cancer: from diagnosis to recurrence 77
A prospective randomized study of laparoscopy and minilaparotomy in the management of benign adnexal masses. 77
Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. 76
Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma. 76
Antiestrogeni e apoptosi 76
Prognostic significance of receptors for epidermal growth factor, estrogen, and progesterone in ovarian cancer. 76
A multicentric trial (Olympia–MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer 76
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. 75
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma. 74
Bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue. 74
Postoperative ileus after para-aortic lymphadenectomy: a prospective study. 73
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. 72
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome. 72
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. 72
Surgical management of advanced ovarian cancer: a 20-years experience in a tertiary gynecologic oncology unit. 72
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters. 71
A prospective study of laparoscopy versus minilaparotomy in the treatment of uterine myomas. 71
Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications 71
Carcinosi peritoneali 70
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer. 69
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery. 69
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 68
Advances in surgical management of cervical cancer. 68
La recidiva: diagnosi e indicazioni alla chirurgia secondaria 68
A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy. 67
Total laparo-endoscopic single site surgery (less) hysterectomy in low-risk early endometrial cancer: technique and preliminary results 66
Laparoendoscopic single-site surgery for the treatment of benign adnexal disease: a prospective trial. 66
Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. 66
Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation 66
M487 PLATELET GEL AND VULVAR CARCINOMA: A PILOT STUDY 66
Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study. 65
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). 65
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study. 64
Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients. 64
Reply to: Laparoscopy or minilaparotomy as minimally invasive surgical approach for uterine leiomyomas? An unsolved question 63
O538 A RANDOMIZED STUDY COMPARING THE USE OF THE LIGACLIP WITH ENSEAL TO PREVENT LYMPHOCELE DURING LAPAROSCOPIC PELVIC LYMPHADENECTOMY FOR GYNECOLOGIC CANCER 63
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. 63
GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy 62
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. 62
Minilaparotomy for type II and III radical hysterectomy: technique, feasibility, and complications. 61
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 61
Robotic single-site hysterectomy (RSS-H) vs. laparoendoscopic single-site hysterectomy (LESS-H) in early endometrial cancer: A double-institution case–control study 61
Comparison of optimal cytoreduction rates in emergency versus non-emergency admissions for advanced ovarian cancer: A multi-institutional study 61
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery. 60
Pre-hysterectomy conization is able to predict response in locally advanced cervical cancer patients undergone to neoadjuvant chemoradiation 60
Simple conization and lymphadenectomy for the conservative treatment of stage ib1 cervical cancer 60
[Prevention of postoperative abdominal adhesions in gynecological surgery. Consensus paper of an Italian gynecologists' task force on adhesions]. 60
Narrow-Band Imaging in Laparoscopic Management of Recurrent Platinum Sensitive Ovarian Cancer 59
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome. 58
Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome. 58
Isterectomia laparoscopica 58
Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis. 58
Laparoscopic myomectomy at 25 weeks of pregnancy: case report. 58
p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer. 58
Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results. 57
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience. 57
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 57
Laparoscopic diagnosis of asymptomatic megaureter. 56
Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer. 56
Il tumore ovarico avanzato: diagnosi e predizione della citoriduzione ottimale 56
Which role for pre-treatment laparoscopic staging? 56
Recurrence: diagnosis and indications for secondary surgery 56
Diagnosi e trattamento dei tumori del collo dell'utero 56
Severe prolonged gastroparesis after cytoreductive surgery in an advanced ovarian cancer patient. 56
Laparoscopia e cancro ovarico: dalla diagnosi alla recidiva 55
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer. 55
Laparoendoscopic single-site surgery (LESS) for ovarian cyst enucleation: report of first 3 cases. 55
Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. 55
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 54
Nuovi fattori prognostici in ginecologia oncologica 54
Morbidity and outcomes after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 205 patients 54
Survival after pelvic exenteration for cervical cancer: a retrospective multicentric study of 158 patients 54
Laparoscopic colorectal resection for bowel endometriosis: feasibility, complications, and clinical outcome. 54
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy. 54
Postoperative pain after conventional laparoscopy and laparoendoscopic single site surgery (LESS) for benign adnexal disease: a randomized trial. 54
Minilaparotomy in early stage endometrial cancer: an alternative to standard and laparoscopic treatment. 53
Tumori maligni del collo dell’utero 53
LARCIST: a new proposed method for the assessment of response to chemotherapy in advanced ovarian cancer patients 53
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 53
Narrow band imaging in borderline ovarian tumor. 53
W110 THE SONOGRAPHIC PREDICTION OF INVASIVE CARCINOMA IN UNILOCULAR-SOLID OVARIAN CYSTS IN PREMENOPAUSAL PATIENTS: A PILOT STUDY 53
Pelvic disease in primary advanced ovarian cancer: the role of peritonectomy of douglas compared with rectosigmoid resection 52
Re: "External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score". 52
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. 52
Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive cervical cancer. 52
Discoid or segmental rectosigmoid resection for deep infiltrating endometriosis: a case-control study. 52
Indicatori di capacità metastatizzante e prognosi nei tumori ovarici 51
[Biological factors with prognostic significance in ovarian cancer]. 51
Totale 6.488
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.136
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 0 0 0 0 0 0 134
2021/20221.115 21 193 9 52 18 20 13 474 11 6 14 284
2022/20231.929 166 314 0 132 202 179 4 91 775 2 44 20
2023/2024494 56 91 34 7 3 2 107 3 1 14 60 116
2024/20251.322 7 176 6 16 169 6 56 138 352 103 153 140
2025/20262.993 202 196 244 460 199 278 476 172 395 299 68 4
Totale 9.384